Promising results from Phase II clinical trials and important biological advances in diagnosis and prognosis were presented at the conference on Molecular Origins of Lung Cancer from Jan. 11-14, 2010 in Coronado, Calif. This conference is jointly sponsored by the AACR and the International Association for the Study of Lung Cancer. In an effort to assist the news media in its coverage of this conference, Roy Herbst, M.D., Ph.D., chief of the section of thoracic medical oncology at the University of Texas M. D. Anderson Cancer Center, hosted a media roundtable on “Personalized Therapy for Lung Cancer: Are We Ready for Prime Time?” on Jan. 12, 2010, at 1:00 p.m. PT, in the Sovereign Room of the Loews Coronado Bay Resort in Coronado, Calif. Read the press release and listen to a recording of the teleconference below to learn more.
* the mp3 of the teleconference (36.5 MB, 53 minutes and 10 seconds)
*On a PC, right mouse click on the "Download" link and select "Save link as..." in Firefox or "Save Target as..." in Internet Explorer.
Subscribe to the AACR RSS news feed
Last Updated: Jan. 13, 2010